North America is expected to witness significant demand for cardiac marker testing devices with high prevalence of lifestyle diseases and high substance and alcohol abuse. For instance, according to the 2018 National Survey on Drug Use and Health, in the U.S., around 164.8 million people aged 12 or older in the U.S. were past month substance users that included tobacco, alcohol, or illicit drugs. Major acquisitions are expected to drive growth of the cardiac marker testing devices market.
Major players operating in the global cardiac marker testing devices market are focused on launching new products to expand their product portfolio. For instance, in May 2016, Royal Philips launched the Minicare I-20 system, a handheld blood test for rapid diagnosis of heart attack.
Read More:
https://bloggerstrive.blogspot.com/2022/06/cardiac-marker-testing-devices-market.html
